SGT-501

SGT-501 · Solid Biosciences Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SGT-501, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) [Phase 1]